stella
beta
Recruiting
Back to NK/T-cell Lymphoma trials
Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations
(1 site)
China
Shanghai General Hospital, Shanghai
View full record on ClinicalTrials.gov
Safety and Efficacy of Anti-EBV Autologous TCR-T Cell Injection in Relapsed/Refractory EBV-Positive Lymphoma — Stella